Can-Fite BioPharma Ltd.
(NYSE Amex Equities : CANF)

( )
CANF After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-1.08%278.821.4%$741.23m
AMGNAmgen, Inc.
-0.74%203.321.3%$386.61m
CELGCelgene Corp.
0.28%104.991.3%$376.93m
GILDGilead Sciences, Inc.
1.09%66.581.0%$375.52m
ILMNIllumina, Inc.
1.15%312.593.5%$232.71m
VRTXVertex Pharmaceuticals, Inc.
-0.29%190.511.9%$216.99m
REGNRegeneron Pharmaceuticals, Inc.
1.23%305.022.6%$210.35m
ALXNAlexion Pharmaceuticals, Inc.
7.40%106.631.9%$181.77m
EXASEXACT Sciences Corp.
-1.52%87.5024.0%$173.24m
AAgilent Technologies, Inc.
0.38%74.971.6%$132.59m
SGENSeattle Genetics, Inc.
1.34%99.966.2%$132.30m
SRPTSarepta Therapeutics, Inc.
-1.67%84.1214.6%$125.03m
BMRNBioMarin Pharmaceutical, Inc.
1.89%69.014.3%$96.83m
ALDRAlder Biopharmaceuticals, Inc.
-0.21%18.8810.2%$94.86m
NKTRNektar Therapeutics
-2.50%16.775.5%$80.05m

Company Profile

Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer. Can-Fite BioPharma was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach Tikva, Israel.